← Back to Search

Device

Vagal Nerve Stimulation for Gastroparesis (VNS Trial)

N/A
Waitlist Available
Led By Linda Nguyen, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (2 weeks prior to initiation), week 4 (7 days), week 8 (7 days)
Awards & highlights

Summary

This trial is testing a hand-held device that stimulates the vagal nerve to help people with gastroparesis, a condition that slows down stomach emptying. The device aims to improve digestion and reduce inflammation by boosting the activity of the vagal nerve. Patients will use the device for a period of time, and their digestive health will be monitored before and after treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (2 weeks prior to initiation), week 4 (7 days), week 8 (7 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (2 weeks prior to initiation), week 4 (7 days), week 8 (7 days) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Effect of Vagal Nerve Stimulation on Gastroparesis Symptoms as Measures by the Gastroparesis Cardinal Symptom Index Daily Diary (GCSI-DD) Questionnaire.
Effect of Vagal Nerve Stimulation on the Gastric Emptying Spirulina Breath Test Emptying Time
Secondary study objectives
Effect of VNS on Mucosal Inflammation
Heart Rate Variability (HRV) as a Measure of the Effect of VNS Therapy on Vagal Tone
Number of Participants With Any Serious or Treatment-emergent Adverse Event (AE) as a Measure of the Safety and Tolerability of VNS in Patients With Gastroparesis
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Idiopathic GastroparesisExperimental Treatment1 Intervention
Patients with idiopathic gastroparesis and delayed gastric emptying. All patients in trial will be giving themselves vagal nerve stimulation for two minutes on each side twice a day in the morning and the night for four weeks starting at visit 3 and ending at visit 5.
Group II: Functional DyspepsiaExperimental Treatment1 Intervention
Patients with functional dyspepsia and normal gastric emptying. All patients in trial will be giving themselves vagal nerve stimulation for two minutes on each side twice a day in the morning and the night for four weeks starting at visit 3 and ending at visit 5.
Group III: Diabetic GastroparesisExperimental Treatment1 Intervention
Patients with diabetic gastroparesis and delayed gastric emptying. All patients in trial will be giving themselves vagal nerve stimulation for two minutes on each side twice a day in the morning and the night for four weeks starting at visit 3 and ending at visit 5.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vagal Nerve Stimulation
2013
Completed Phase 1
~30

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,370 Total Patients Enrolled
6 Trials studying Gastroparesis
174 Patients Enrolled for Gastroparesis
Andres Gottfried, MD PHDStudy DirectorStanford University
Linda Nguyen, MDPrincipal InvestigatorStanford University
5 Previous Clinical Trials
642 Total Patients Enrolled
3 Trials studying Gastroparesis
120 Patients Enrolled for Gastroparesis
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top